UA99259C2 - Лечение ожирения антагонистами мускаринового рецептора м1 - Google Patents

Лечение ожирения антагонистами мускаринового рецептора м1

Info

Publication number
UA99259C2
UA99259C2 UAA200900269A UAA200900269A UA99259C2 UA 99259 C2 UA99259 C2 UA 99259C2 UA A200900269 A UAA200900269 A UA A200900269A UA A200900269 A UAA200900269 A UA A200900269A UA 99259 C2 UA99259 C2 UA 99259C2
Authority
UA
Ukraine
Prior art keywords
mantagonist
acetylcholine receptor
muscarinic acetylcholine
treating obesity
antagonists
Prior art date
Application number
UAA200900269A
Other languages
English (en)
Ukrainian (uk)
Inventor
Брайан СИД
Джордан Мечаник
Original Assignee
Теракос, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Теракос, Инк. filed Critical Теракос, Инк.
Publication of UA99259C2 publication Critical patent/UA99259C2/ru

Links

Abstract

Изобретение относится к области медицины и касается способа содействия снижению массы тела или облегчения поддержания стабильной массы тела, который включает введение индивиду с ожирением или с чрезмерной массой тела телензепина и антидепрессанта, выбранного из группы, которая состоит из сертралина, циталопрама, эсциталопрама, венлафаксина и сибутрамина, в терапевтически эффективном количестве с целью снижения массы тела, благодаря чему активируется снижение массы тела или облегчается поддержание стабильной массы тела. Изобретение также касается фармацевтической композиции и набора.
UAA200900269A 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1 UA99259C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80506606P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
UA99259C2 true UA99259C2 (ru) 2012-08-10

Family

ID=40829458

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200900268A UA98938C2 (ru) 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1
UAA200900269A UA99259C2 (ru) 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200900268A UA98938C2 (ru) 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Country Status (2)

Country Link
CN (2) CN101472476B (ru)
UA (2) UA98938C2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
PL2632468T3 (pl) * 2010-10-25 2018-04-30 University Of Manitoba Kompozycje terapeutyczne do leczenia symetrycznej polineuropatii cukrzycowej

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953430A (en) * 1975-02-24 1976-04-27 American Cyanamid Company Substituted benzodiazepin-10-ones and method of use
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
EP1052994A2 (en) * 1998-02-02 2000-11-22 Trustees Of Tufts College Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
AU2001288972A1 (en) * 2000-09-11 2002-03-26 Sepracor, Inc. Antipsychotic sulfonamide-heterocycles, and methods of use thereof
KR20030081520A (ko) * 2001-03-14 2003-10-17 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ１ 안타고니스트를 유효 성분으로서 함유하는 울병의치료제
WO2004078113A2 (en) * 2003-03-04 2004-09-16 Pharmacia Corporation Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents
BRPI0506807A (pt) * 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica

Also Published As

Publication number Publication date
CN101472571B (zh) 2012-11-14
CN101472571A (zh) 2009-07-01
CN101472476B (zh) 2013-10-30
UA98938C2 (ru) 2012-07-10
CN101472476A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
WO2009050136A3 (en) Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome
EP2056818A4 (en) COMPOSITIONS AND METHODS FOR NEUROPROTECTION
EP2478907A3 (en) Methods and compositions for treating cancer
MX2010002781A (es) Combinacion novedosa de angentes terapeuticos.
WO2008024485A3 (en) Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent
EP2032127A4 (en) TREATMENT OF PSYCHOLOGICAL PATHOLOGIES USING M1 MUSCARINIC RECEPTOR ANTAGONISTS
WO2007123984A3 (en) Pre-mixed, ready-to-use pharmaceutical compositions
WO2007098113A3 (en) Ccr3 inhibition for ocular angiogenesis and macular degeneration
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
WO2012037410A3 (en) Estrogen receptor modulators and uses thereof
UA94909C2 (ru) Фармацевтическая композиция нейроактивного стероида и ее применение
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
WO2006055752A3 (en) INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME
WO2006036770A3 (en) Combination therapy for the treatment of obesity
WO2004110368A3 (en) Combination therapy for the treatment of hypertension
WO2006135638A3 (en) Tanaproget compositions containing ethinyl estradiol
WO2006058059A3 (en) Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
WO2009140642A3 (en) Tricyclic antagonists of prostaglandin d2 receptors
WO2010003127A3 (en) Antagonists of prostaglandin d2 receptors
WO2006065722A3 (en) Compositions and methods for pulmonary conditions
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
NZ588913A (en) Liver cancer drug
WO2009145989A3 (en) Aminoalkylphenyl antagonists of prostaglandin d2 receptors
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors